Jemincare Announces 6 Approvals of Clinical Trials for its Innovative Drugs
- Written by PR Newswire
SHANGHAI, Dec. 26, 2023 /PRNewswire/ -- Jemincare, a leading pharmaceutical company from China, announced that its wholly owned subsidiary company, Shanghai Jemincare Pharmaceutical Co., Ltd., recently received 6 approvals of clinical trials for its innovative drugs in the field of cancer, kidney and anti-infectious diseases, including 4...
Read more: Jemincare Announces 6 Approvals of Clinical Trials for its Innovative Drugs














